Skip to main content

New: AI Privacy Impact Assessments for teams shipping AI features. Learn about AI-PIAs

Digital health & life sciences

Privacy & Security for AI Scribe & Clinical AI Vendors

An AI scribe or clinical AI vendor's privacy and security program exists to answer one question before every deal closes: can this product touch protected health information and still pass a custodian's review? We build the PIA kit, the agent-or-electronic-service-provider position, the retention rule for raw consult audio, and the SOC 2 or HIPAA evidence that Infoway's AI Scribe Program, Ontario's provincial program, and individual hospital procurement teams now expect before a clinician ever opens the app.

Reviewed by the Privacy Horizon team · Last reviewed

Who this is for

Founders, CTOs, medical directors and the first compliance hire at Canadian ambient-scribe and clinical-AI companies — usually 5 to 100 people, venture-funded, selling into primary care, allied health and hospital systems on both sides of the border.

Teams applying to Canada Health Infoway's national AI Scribe Program or Ontario's MOH/Ontario Health program, where vendor pre-qualification runs through privacy, cybersecurity, EMR integration and usability review before a single clinician receives a licence.

Vendors converting a hospital pilot into a signed contract, where the procurement questionnaire now asks for a PIA, a threat and risk assessment, SOC 2 or ISO 27001 evidence, and a documented answer on whether consult audio ever leaves Canadian infrastructure.

Companies with US clinic customers that need a signed Business Associate Agreement and a documented HIPAA risk analysis before go-live, alongside investors probing exactly what rights the company holds over training data drawn from patient encounters.

Doctor, men and consultation with patient, tablet and hospital for wellness, advice and medical feedback. People, healthcare and services with report, news and review info on appli

Services

Privacy & security services for ai scribe & clinical ai vendors

Each service below is scoped for how ai scribe & clinical ai vendors actually operate — their systems, their regulators and the reviews they face.

What you hold

What a scribe or clinical AI vendor's program has to cover

The environment is narrower than a typical health-tech product but far more sensitive at its centre, because the artifact at stake is the recorded voice of a clinical encounter.

Raw consult audio and diarized transcripts

The most sensitive record the company holds, captured on a clinician's phone or an exam-room mic, then split by speaker and pushed through automatic speech recognition before a human ever reads it.

The ASR/LLM inference stack

Azure OpenAI, AWS Bedrock, Google Vertex or a Whisper-class speech model, plus the vector stores that hold embeddings, each a point where patient speech leaves the vendor's direct control.

EMR integration points

Connections into TELUS PS Suite, Med Access, CHR, QHR Accuro, OSCAR Pro, or Epic and Oracle Health in hospital settings, where a draft note is written back into the legal medical record.

Clinician devices as capture endpoints

Smartphones and exam-room microphones enrolled through the company's MDM, each one a live audio channel that needs the same device controls as any other endpoint holding PHI.

Consent flags and the Patient Consent Toolkit workflow

The per-encounter record of whether a patient agreed to be recorded, and what happens operationally — and to their care — when they decline.

Model training and evaluation datasets

Any corpus built from real encounters, clinician corrections or QA review, which carries the highest legal exposure of anything the company stores.

Regulatory map

The regulatory map a custodian assumes a vendor already knows

Buyers in this niche have read the guidance before they call, so a vendor that cannot speak this language loses credibility in the first five minutes.

PHIPA agent or electronic service provider status

Under Ontario Regulation 329/04, an ESP is barred from using PHI except as necessary to deliver the service, and the custodian — the clinician or clinic — remains legally responsible for the PIA and the consent process.

Read our guide →

The IPC's January 2026 guidance on AI scribes

Ontario's privacy regulator published considerations aimed directly at this product category: PIAs, contractual limits on vendor use of PHI, audio retention and destruction, and a human-in-the-loop expectation before a note is finalized.

Primary source →

Alberta's pre-filing requirement

Under the Health Information Act, a custodian must file a Privacy Impact Assessment with the OIPC before implementing a system like a scribe, which means an Alberta deal cannot close until the vendor has supplied a usable PIA kit.

Primary source →

PIPEDA and the OPC's generative AI principles

The vendor's own commercial handling of personal information sits under PIPEDA, and the OPC's December 2023 principles add expectations around consent, necessity, traceable outputs and adversarial testing of the model itself.

Primary source →

HIPAA business associate status for US customers

A vendor serving a US clinic is a business associate under the Security Rule, and that status flows down every sub-processor in the LLM and cloud chain through a sub-BAA.

Read our guide →

Administrative monetary penalties under PHIPA

AMPs of up to $50,000 for an individual and $500,000 for an organization have applied under PHIPA since January 1, 2024, raising the cost of a vendor contract that leaves a custodian exposed.

Primary source →

What goes wrong

The incident patterns specific to ambient scribes and clinical AI

These are the failure modes that show up in Infoway and hospital procurement checklists, because they are the ones the regulator has already named.

  • Secondary use of PHI for model training

    Using recorded encounters to improve the product without valid consent or genuine de-identification is the central risk the IPC's guidance targets, and it is usually the first architecture question a hospital reviewer asks.

    Source →

  • Retention sprawl of raw audio

    Recordings kept 'temporarily' for quality assurance tend to accumulate rather than expire, turning a QA convenience into the largest single breach exposure the company carries.

  • Sub-processor compromise in the ASR/LLM chain

    A breach at a transcription or model-hosting sub-processor triggers PHIPA breach duties and BAA notification clocks at the same time, across every custodian the vendor serves.

  • Insider access to transcripts by ML or QA staff

    Engineers and quality reviewers with standing access to identifiable transcripts are exactly the population the ESP 'no use except as necessary' rule is written to constrain.

  • Credential stuffing on clinician accounts

    Accounts without multi-factor authentication remain the entry point regulators keep pointing to after major consumer-data investigations, and a clinician account is a door into live patient encounters.

  • Prompt injection and cross-tenant leakage

    Shared inference infrastructure serving multiple clinics creates a path for one tenant's prompts or outputs to influence another's, a risk the OPC's developer-duty principles expect vendors to test for.

When organisations call us

When AI scribe and clinical AI vendors call Privacy Horizon

The calendar for this niche runs on program cohort windows and hospital budget cycles more than on any single statutory deadline.

  • A national or provincial program application opens

    Canada Health Infoway's AI Scribe Program and Ontario's MOH/Ontario Health program both pre-qualify vendors on privacy and cybersecurity evidence, and the application window is the moment that evidence has to already exist.

  • The IPC guidance lands on a custodian's desk

    A clinic or hospital privacy officer arrives with the January 2026 checklist in hand, and the vendor needs a PIA, a consent workflow and an audio-retention answer ready the same day.

  • A hospital pilot moves toward a signed contract

    What started as a departmental trial becomes a formal procurement, complete with a security questionnaire, a threat and risk assessment request, and a demand for SOC 2 or ISO 27001 evidence.

  • A US clinic asks for a Business Associate Agreement

    The first American customer wants a signed BAA and evidence of a documented HIPAA risk analysis before any patient audio crosses the border.

  • Investor diligence opens the training-data question

    A term sheet arrives, and the diligence team wants to know exactly what rights the company holds over data drawn from real clinical encounters before they sign.

  • Hospital fiscal year-end tightens vendor review

    Procurement teams revisit vendor risk ahead of the March 31 fiscal year-end, and a vendor without current evidence risks losing a renewal it assumed was routine.

AI Scribe & Clinical AI Vendors: privacy & security questions, answered

Pre-qualification is required to access the funded cohort of clinicians under the national AI Scribe Program, not to sell an AI scribe generally. Vendors outside the program can still sell directly to clinics and hospitals, but they lose the credibility shortcut pre-qualification provides and face the same privacy and security bar case by case, deal by deal.

The clinician or clinic almost always remains the custodian; the vendor is typically an agent, an electronic service provider, or both, depending on how the product is used. That distinction matters because the custodian owns the PIA and the patient consent process, while the vendor's contract has to prove it will only use PHI as necessary to deliver the service.

Arrive with a PIA kit already built for your product, a clear written answer on whether you train on customer data, and evidence — SOC 2, ISO 27001, or both — that maps to the questionnaire a hospital privacy office is likely to send. Vendors who wait for the questionnaire before starting this work lose months of a procurement cycle.

It is a strong selling point rather than a strict requirement, since many custodians accept US-region inference if the cross-border disclosure is documented and assessed in the PIA. Where residency is offered, it removes an entire category of question from procurement review, which is why most competitive vendors lead with it.

The product handles an artifact — raw consult audio — that a general SaaS company never touches, and the regulator has published guidance naming that artifact specifically. Agent and electronic-service-provider status, per-encounter consent, and the no-training question are not generic SaaS concerns; they are the first three questions every clinical buyer asks.

Treat it as a living document tied to the product, not the deal. Every model update, new sub-processor, or EMR integration changes the risk picture the IPC guidance asks custodians to assess, so a PIA that goes stale becomes a liability the next time a hospital or provincial program reviews it.

What's Protecting Your Business from the Next Threat?

Don't wait for a breach to expose your vulnerabilities. Let Privacy Horizon secure your data, ensure compliance, and build lasting trust.

(647) 622-2644

Free, no obligation

Get a quote

Tell us what you need and we'll come back within one business day with a tailored quote.

We only use your details to respond to this request.